# Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension

> **NCT00325637** · PHASE3 · COMPLETED · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 250 (actual)

## Conditions studied

- Hypertension
- Stroke

## Interventions

- **DRUG:** cilnidipine

## Key facts

- **NCT ID:** NCT00325637
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-07
- **Final completion:** 2007-08
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2008-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00325637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00325637, "Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00325637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*